Leucovorin for the Treatment of 5 q Minus Syndrome - Related Studies

Leucovorin for the Treatment of 5 q Minus Syndrome

This study has been completed.

Study NCT00004997. Last updated on March 3, 2008. Information provided by National Institutes of Health Clinical Center (CC)

Find Related Studies by Searching for the Conditions, Interventions, and Sponsors found in this study:


1	Conditions listed in this trial
		5q Minus Syndrome
		Myelodysplastic Syndrome

2	Additional conditions recognized in this trial
		Myelodysplastic Syndromes
		Preleukemia
		Syndrome

3	More general conditions related to this trial
		Bone Marrow Diseases
		Disease
		Hematologic Diseases
		Neoplasms
		Pathologic Processes
		Precancerous Conditions

4	Interventions listed in this trial
		Leucovorin

5	More general drug interventions related to this trial
		Growth Substances
		Micronutrients
		Pharmacologic Actions
		Physiological Effects of Drugs
		Vitamin B Complex
		Vitamins

6	Sponsors listed in this trial
		National Institutes of Health Clinical Center (CC)